Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey

被引:49
作者
Decousser, JW
Pina, P
Picot, E
Delalande, C
Pangon, B
Courvalin, P
Allouch, P [1 ]
机构
[1] Ctr Hosp A Mignot, Versailles, France
[2] Inst Pasteur, Paris, France
关键词
bloodstream infection; antimicrobial susceptibility; VRSA; Streptococcus pneumoniae; France;
D O I
10.1093/jac/dkg201
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
All bloodstream strains, total 1463, isolated during a 1 month period in 105 hospitals representing all geographical areas in France were collected to study their antimicrobial susceptibility. The three major species were Escherichia coli, Staphylococcus aureus and coagulase-negative staphylococci. Among the 242 S. aureus, 87 were resistant to methicillin and among those 99% were resistant to ciprofloxacin, 11.5% to gentamicin, 1% to quinupristin/dalfopristin and 8% were heterogeneously resistant to vancomycin. Study of the methicillin-resistant S. aureus indicated that 12 clones had disseminated in French hospitals, six being heterogeneously resistant to vancomycin. Among the Streptococcus pneumoniae, 43% showed decreased susceptibility to the penicillins and 42% to erythromycin. One isolate was highly resistant to fluoroquinolones. Gentamicin, cefotaxime, ciprofloxacin and gatifloxacin resistance was rare in Enterobacteriaceae with 95% of strains susceptible. The incidence of extended-spectrum beta-lactamases was quite low. Moreover more than 25% of Pseudomonas aeruginosa strains were resistant to ciprofloxacin and gentamicin. The magnitude of antibiotic resistance in bloodstream isolates, in particular Gram-positive bacteria, emphasizes the importance of hospital control measures, rational prescribing policies and new vaccine strategies.
引用
收藏
页码:1213 / 1222
页数:10
相关论文
共 43 条
  • [1] [Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P565
  • [2] Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus
    Aucken, HM
    Warner, M
    Ganner, M
    Johnson, AP
    Richardson, JF
    Cookson, BD
    Livermore, DM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) : 639 - 640
  • [3] PULSED-FIELD GEL-ELECTROPHORESIS AS A REPLACEMENT FOR BACTERIOPHAGE-TYPING OF STAPHYLOCOCCUS-AUREUS
    BANNERMAN, TL
    HANCOCK, GA
    TENOVER, FC
    MILLER, JM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) : 551 - 555
  • [4] An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: Risk factors and microbiological associations
    Byington, CL
    Spencer, LY
    Johnson, TA
    Pavia, AT
    Allen, D
    Mason, EO
    Kaplan, S
    Carroll, KC
    Daly, JA
    Christenson, JC
    Samore, MH
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (04) : 434 - 440
  • [5] *CDC, 2002, MMWR-MORBID MORTAL W, V51, P902
  • [6] Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals
    Chesneau, O
    Morvan, A
    El Solh, N
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) : 887 - 890
  • [7] *COM TECHN NAT INF, 1999, CCLIN PARIS NORD WEB
  • [8] Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America
    Diekema, DJ
    Pfaller, MA
    Jones, RN
    Doern, GV
    Kugler, KC
    Beach, ML
    Sader, HS
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 13 (04) : 257 - 271
  • [9] Streptococcus pneumoniae bacteraemia in Belgium:: differential characteristics in children and the elderly population and implications for vaccine use
    Flamaing, J
    Verhaegen, J
    Peetermans, WE
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) : 43 - 50
  • [10] Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY Antimicrobial Surveillance Program, 1997 and 1998
    Fluit, AC
    Jones, ME
    Schmitz, FJ
    Acar, J
    Gupta, R
    Verhoef, J
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) : 454 - 460